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Highlights 
 Self-reported, MMSE-defined, and autobiographical memory deficits are common 
following ECT. 
 Agreement between these memory deficits is poor, and their correlates are discrete.  
 Serum cortisol levels correlate significantly with self-reported memory complaints. 
 People receiving ECT need periodic assessments evaluating multiple cognitive domains. 
 
Abstract 
Background: Cognitive deficits, self-reported or found following electroconvulsive therapy 
(ECT), and their correlates are diverse. Despite the characteristics of people receiving ECT in 
Asia differ widely from the west, pertinent research from Asia remains sparse.  
Methods: We investigated the correlates of self-reported, mini-mental status examination 
(MMSE) defined, and autobiographical memory deficits in a cohort that received ECT in a 
south Indian tertiary-care setting. 76 consecutive consenting people were recruited within 
seven days of completing their ECT course. Memory was assessed by a subjective Likert 
scale, MMSE, and an autobiographical memory scale (AMS). Psychopathology was assessed 
by brief psychiatric rating scale, and serum cortisol levels were estimated by chemi-
luminescence immunoassays. Relevant sociodemographic and clinical data were collected 
from the participants, and their medical records. The correlates were analysed using 
generalised linear models after adjusting for the effects of potential confounders.  
Results: Self-reported, MMSE-defined, and autobiographical memory deficits were present 
in 27.6% (95%CI 17.6-37.7%), 42.1% (95%CI 31.0-53.2%), and 36.8% (95%CI 26.0-47.7%) 
of participants, respectively. Agreement between the memory deficits was poor. Age, less 
education, duration of illness, hypothyroidism, and past history of another ECT course were 
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significantly associated with MMSE-defined deficits. Age, anaemia, past ECT course, and 
pre-ECT blood pressure were significantly associated with autobiographical memory deficits, 
while residual psychopathology and cortisol levels were significantly associated with self-
reported memory deficits.  
Conclusion: Self-reported, MMSE-defined, and autobiographical memory deficits are 
common at the completion of ECT course, and their correlates differ. All service users 
receiving ECT need periodic cognitive assessments evaluating multiple cognitive domains.  
Key words: Electroconvulsive therapy; Memory; Cognition; Cortisol; Schizophrenia 
 
 
1. Introduction 
 Assessment of memory deficits following electroconvulsive therapy (ECT) is 
complex. Firstly, cognitive deficits following ECT are not global, but discrete. Routine 
cognitive assessment instruments like mini-mental status examination (MMSE) may fail to 
elicit the deficits in specific domains such as autobiographical memory (Sackeim, 2014). 
Secondly, psychiatric disorders necessitating ECT per se can contribute to the cognitive 
deficits, and it is difficult to disentangle the effects of the disorders and their treatment. 
Thirdly, opinions regarding ECT are often strong and polarised (Carney and Geddes, 2003). 
Many service users have reported severe enduring memory deficits following ECT 
(Chakrabarti et al., 2010; Rose et al., 2003). However, studies employing objective cognitive 
assessments have corroborated only acute and brief memory deficits (Semkovska and 
McLoughlin, 2010; UK-ECT-Review-Group, 2003; Versiani et al., 2011; Wang et al., 2015). 
The findings of service users-led and professionals-led assessments differ widely, and 
inherent observer bias is one of the potential explanations (Rose et al., 2003). Professionals 
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tend to focus on laboratory evidence for brain damage and objective memory assessment 
findings (Fink, 2007). They may fail to address the distress and disability, reported by some 
service users (Rose et al., 2004). Studies evaluating self-reported and objective memory 
deficits in a cohort of service users that received ECT are sparse (Rajkumar et al., 2006).  
 Available studies have mostly evaluated the correlates of memory deficits, defined by 
standard cognitive assessments, following ECT (Andrade and Bolwig, 2014; McCall et al., 
2000; Neylan et al., 2001; Sackeim et al., 2000; Shapira et al., 2000; Sobin et al., 1995). They 
have principally investigated the associations with many treatment-related variables, such as 
electrode placements, treatment schedules, electrical dosing, wave pattern, seizure duration, 
and anaesthesia. Bilateral ECT (UK-ECT-Review-Group, 2003), sine-waveform  (Pisvejc et 
al., 1998), more frequent ECT schedules (Shapira et al., 2000), and higher suprathreshold 
electrical dosing (McCall et al., 2000) can increase the risk for memory deficits. Moreover, 
individual-related factors such as advancing age, female gender, and lower premorbid 
intelligence have been associated with memory deficits (Sackeim et al., 2007; Sobin et al., 
1995). Higher cortisol levels have been reported to increase the risk for memory deficits 
following ECT (Neylan et al., 2001), and pertinent glucocorticoid mechanisms have been 
hypothesised (Nagaraja et al., 2007). A multifactorial model for the neurocognitive effects of 
ECT including various individual, illness, and treatment-related variables has been proposed 
recently (McClintock et al., 2014).  
 Systematic studies investigating the correlates of self-reported and autobiographical 
memory deficits remain sparse. Investigating the associations of these memory deficits with 
various individual, illness, and treatment-related variables may help to broaden our 
understanding of these deficits, to identify people at risk of developing these deficits, and to 
develop potential approaches minimising these memory deficits following ECT (McClintock 
et al., 2014). Besides, majority of service users receiving ECT are older women with 
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depression in Europe and USA, but ECT is mostly used for younger men with schizophrenia 
in Asia (Leiknes et al., 2012). This limits the generalisability of the findings of western 
studies investigating ECT-related memory deficits to Asian settings, and relevant systematic 
studies from Asia remain few (Leiknes et al., 2012). Hence, we aimed to investigate the self-
reported, MMSE-defined, and autobiographical memory deficits in a cohort that completed a 
course of ECT in a south Indian tertiary-care psychiatric facility.  
2. Material and Methods 
2.1. Study design: We adopted a case-control design for investigating the study objectives. 
2.2. Setting: The department of psychiatry, Christian Medical College (CMC), Vellore, India, 
is a tertiary psychiatric facility providing mental health services for service users from India. 
This 122-bed hospital has a daily outpatient clinic, and provides short-term inpatient care. 
Service users and their family members stay in independent cottages during the period of 
hospitalisation, which often ranges from four to eight weeks. The emphasis is on a multi-
disciplinary approach using a wide variety of pharmacological and psychological therapies.  
2.3. Practice of ECT: The department has a dedicated ECT suite, and follows twice weekly 
ECT schedule (Mondays and Thursdays). Bilateral fronto-temporal electrode placement is the 
norm, and all ECTs are completed under intravenous sodium thiopental (2-3 mg/kg) 
anaesthesia, and intravenous suxamethonium chloride (0.5-1 mg/kg) muscle relaxation. 
Niviqure versatile ECT system (Niviqure Meditech Private Limited, Bengaluru, India) is used 
to deliver brief-pulse constant current electrical stimuli. A multi-disciplinary team including 
two psychiatrists, one anaesthetist, and 2-4 psychiatric nurses delivers all ECTs. Motor 
seizure duration is monitored using the “cuff” method (Chung, 2000). During the first ECT 
session of all service users, stimulus intensity is empirically titrated to elicit at least 25 
seconds of motor seizures. This electrical dose is continued on subsequent sessions, except 
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when there are specific indications to change the stimulus intensity. Following ECT, all 
service users are monitored in a recovery room within the ECT suite. Therapeutic decision on 
using ECT is made through consensus among the treating team. The treating psychiatrists 
explained the details of ECT, and its risks and benefits to the servicer users and to their 
family, and obtained written informed consent. The treating team decided the number of 
ECTs, ECT methods, and when to stop the ECT course. The authors did not influence any of 
these decisions.  
2.4. Participants: All consecutive inpatients or outpatients, who were at least 18 years old, 
and completed or withdrew from a course of ECT in the department were invited to 
participate. All consenting eligible service users were recruited in this study. Service users 
with severe medical comorbidity, intellectual disability, sensory impairment, or severe 
psychopathology precluding the assessment were excluded. The nature and purpose of this 
study, involved procedures, expected duration of involvement, and potential risks and 
benefits of this study were explained to all participants and their nearest relatives, and written 
informed consent was obtained from all participants. The protocol of this study was approved 
by the institutional review board of CMC, Vellore, India.  
2.5. Assessment: All participants were assessed by two independent investigators in two 
sessions within one week after completing or withdrawing from their ECT course. Each 
assessment session lasted for approximately forty-five minutes. One investigator assessed the 
service users’ memory by the following, (i) A Likert scale: each service user subjectively 
rated his/her memory deficits following ECT on a six-point Likert scale. The responses 
included no, minimal, mild, moderate, severe, and extremely severe memory deficits; (ii) 
MMSE: It is a 30-item screening measure of general cognitive ability (Folstein et al., 1975). 
Its psychometric properties have been extensively studied (Lopez et al., 2005; Tombaugh and 
McIntyre, 1992); (iii) Autobiographical Memory Scale (AMS): Autobiographical memory 
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was assessed by a culturally adapted 25-item AMS, which has already been used to 
investigate autobiographical memory deficits in an earlier cohort that received ECT in the 
department (Mohan et al., 2009). The AMS included major domains of a person’s life, such 
as schooling, place of work, neighbourhood, and family events. Knowledgeable collateral 
source information from the next of kin was used as the criterion standard for evaluating the 
degree of recall of the participants (Dreyfus et al., 2010; Viswanath et al., 2013). Each AMS 
item was scored on a three-point scale from 0 (cannot remember anything) to 2 (can 
remember everything), and the total score of AMS ranged from 0 to 50. 
Another independent investigator, blind to the results of memory assessment, assessed 
the psychopathology of all participants using 18-items Brief Psychiatric Rating Scale 
(BPRS). The BPRS is a short clinician-rated scale for measuring the severity of 
psychopathology, and it  covers a broad range of areas including thought disturbance, 
emotional withdrawal, anxiety, depression, hostility, and suspiciousness (Overall and 
Gorham, 1962). The 18 items are rated from one to seven with a total score ranging from 18 
to 126. The investigator interviewed all participants and their relatives using a structured 
proforma (Supplementary material) to collect data on individual-related variables including 
age, gender, marital status, urbanicity, education, and occupation. Moreover, three ml of 
peripheral blood sample was collected from all participants at 8 am (± 30 minutes) within one 
week after their course of ECT. Serum cortisol level was estimated using this sample by 
chemi-luminescence immunoassay on ADVIA Centaur XP immunoassay system (Siemens 
Medical Solutions USA, Inc., Malvern, PA, USA) in the department of clinical biochemistry, 
CMC, Vellore, India (Miller and Crapo, 1994). 
2.6. Review of medical records: The department maintains comprehensive medical records, 
and ECT records for all services users receiving ECT. The investigator, blind to the results of 
memory assessment, accessed the records of the participants with their written informed 
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consent. Data on illness-related variables including clinical diagnosis, family history of 
neuropsychiatric morbidity, pre-ECT suicidal risk, age of onset of illness, duration of current 
episode of illness, total duration of illness, duration of untreated psychosis, pre-ECT MMSE 
scores, axis-II comorbidity, and medical co-morbidity, and on treatment-related variables 
including previous courses of ECT, co-medications, hospitalisation, pre-ECT cognitive 
function, pre-ECT physical examination, and number of ECTs in the current course of ECT 
were collected from the records. Data on the dose of anaesthesia, dose of muscle relaxant, 
pre-ECT blood-pressure (BP) and oxygen saturation, post-ECT BP and oxygen saturation, 
post-ictal confusion, electrical stimulus (millicoulombs), motor seizure duration, and post-
ECT recovery were collected for each ECT session of all participants. When there were any 
discrepancies, the illness and treatment-related data were verified with the participants’ 
relatives and their treating team with their consent. 
2.7. Case definition of memory deficits: Self-reported memory deficit was defined by the 
participant reporting at least moderate severity of memory deficits in the Likert scale. 
MMSE-defined memory deficit was defined by the participant failing at least seven items of 
MMSE following ECT. Autobiographical memory deficit was defined by the participant 
scoring less than the median value of total AMS score of the cohort following ECT. 
2.8. Statistical analyses: Participants’ characteristics and their clinical and treatment profiles 
were initially analysed by descriptive statistics. Differences between subgroups were 
analysed by appropriate tests of statistical significance. Agreement between the self-reported, 
MMSE-defined, and autobiographical memory deficits were assessed by kappa statistics. The 
associations of the memory deficits with various individual, illness, and treatment-related 
variables were analysed by generalised linear models with binomial distribution and log-link 
function. Each model included the memory deficit as the dependent variable, a hypothesised 
explanatory variable, and age and number of ECTs as covariates. Adjusted risk ratios (ARR) 
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were derived from the exponentiated estimates of the regression coefficients of these models. 
ARR were preferred over the odds ratios, because the outcome event, memory deficits, were 
common (>10%). Robust standard errors were estimated to calculate the 95% confidence 
intervals (CI) of ARR. Considering multiple testing, Benjamini-Hochberg false discovery rate 
(5%) correction was done. All analyses were performed using the statistical software STATA 
13.1 (StataCorp, TX, USA), and SPSS 21.0 (Armonk, NY, USA). 
3. Results 
3.1. Participant characteristics: 83 service users, who completed or withdrew from a course 
of ECT, were assessed for their eligibility, and 76 (91.6%) of them fulfilled the eligibility 
criteria. As none refused consent, 76 participants were recruited. Seven service users, who 
were excluded, did not differ significantly from the participants on their gender (z=-0.03; 
p=0.98), age (t=-0.10; p=0.92), and the number of years of education (t=0.28; p=0.78). Table-
1 presents the sociodemographic and clinical characteristics of the participants. Majority of 
the participants were single (n=41; 54.0%), unemployed (n=45; 59.2%), and from rural areas 
(n=40; 52.6%). Median number of ECTs during the ECT course was 10 (range 6-13). Co-
medications included antidepressants (n=10; 13.2%), first (n=20; 26.3%) or second 
generation (n=68; 89.5%) antipsychotics, benzodiazepines (n=43; 56.6%), and 
anticholinergics (n=46; 60.5%). Numbers of participants, who had dyslipidaemia, microcytic 
hypochromic anaemia, and hypothyroidism, were 20 (26.3%), 13 (17.1%), and 5 (6.6%), 
respectively. Mean serum levels of morning cortisol, creatinine, and thyroid stimulating 
hormone of the participants were 16.35 (SD=5.30) µg/dL, 0.92 (SD=0.21; n=73) mg/dL, and 
3.67 (SD=11.66; n=65) mg/dL, respectively. Mean serum cortisol levels of participants with 
schizophrenia (16.65 µg/dL; 95%CI 14.94-18.36 µg/dL), mania (14.69 µg/dL; 95%CI 12.48-
16.90 µg/dL), depression (17.96 µg/dL; 95%CI 12.47-23.46 µg/dL), and other diagnoses 
(15.73 µg/dL; 95%CI 12.36-19.11 µg/dL) did not differ significantly (F=0.74; df=3; p=0.53).  
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3.2. Presence of memory deficits: 21 participants (27.6%; 95% CI 17.6-37.7%) reported 
memory deficits. Numbers of participants reporting moderate, severe, and extremely severe 
memory deficits were 15 (19.7%), 4 (5.3%), and 2 (2.6%), respectively. 29 (38.2%) 
participants did not report any memory deficits, while ten (13.2%) reported minimal deficits. 
MMSE-defined memory deficits were present in 42.1% (95% CI 31.0-53.2%) of the 
participants. Pre-ECT cognitive assessment had been documented in 72 ECT records, and 27 
(37.5%; 95% CI 26.3-48.7%) of them showed seven or more points decline in their post-ECT 
MMSE scores. Median AMS total score in this cohort was 40 (range 24-50; IQR=21), and 28 
(36.8%; 95% CI 26.0-47.7%) participants scored below 40. 52 participants (68.4%; 95% CI 
58.0-78.9%) had at least one of these memory deficits (Supplementary table-1). 
3.3. Agreement between memory deficits: Table-2 presents the agreement between self-
reported, MMSE-defined, and autobiographical memory deficits. Self-reported memory 
deficits showed poor agreement with MMSE-defined and autobiographical memory deficits 
(Figure-1). However, agreement between MMSE-defined memory deficits and 
autobiographical memory deficits was fair (Viera and Garrett, 2005).  
3.4. Correlates of memory deficits: Table-3 and Table-4 present the associations of the 
memory deficits with various individual, illness, and treatment-related variables. Age, less 
years of education, duration of illness more than two years (median value), hypothyroidism, 
and having received more than one course of ECT were significantly associated with MMSE-
defined memory deficits. Autobiographical memory deficits were significantly associated 
with age, urbanicity, anaemia, having received more than one course of ECT, and higher pre-
ECT BP. Moreover, self-reported memory deficits were significantly associated with residual 
psychopathology and serum cortisol levels. Mean total BPRS scores, and serum cortisol 
levels in those, who reported moderate to extremely severe memory deficits, were 34.0 
(SD=8.0), and 19.51 (SD=5.23) µg/dL, respectively, while mean total BPRS scores, and 
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serum cortisol levels in those, who did not report such memory deficits, were 25.7 (SD=8.9), 
and 14.95 (SD=4.79) µg/dL, respectively. After Benjamini-Hochberg correction, only the 
associations between self-reported memory deficits and serum cortisol levels, as well as 
between autobiographical memory deficits and mean pre-ECT diastolic BP were statistically 
significant (p=0.0375). Marital status, unemployment, clinical diagnosis of schizophrenia, 
bipolar disorder, or depression, family history of psychosis, age of onset of illness, duration 
of current episode of illness, duration of untreated psychosis, axis-II comorbidity, 
antipsychotic or antidepressant co-medications, pre-ECT MMSE scores, and post-ECT BP 
were not significantly associated with self-reported, MMSE-defined, or autobiographical 
memory deficits in this cohort.  
4. Discussion 
 This is the largest naturalistic study conducted to date in Asia that has investigated the 
agreement, and correlates of self-reported, MMSE-defined, and autobiographical memory 
deficits in a cohort that received ECT. It has demonstrated the poor agreement between self-
reported and objective memory deficits. It has found specific correlates of self-reported, 
MMSE-defined, and autobiographical memory deficits.  
 Previous studies have established the associations of MMSE-defined memory deficits 
with electrode placements, treatment schedules, electrical stimulus dosing, wave pattern, and 
anaesthetic parameters (McCall et al., 2000; McClintock et al., 2014; Shapira et al., 2000; 
Sobin et al., 1995; UK-ECT-Review-Group, 2003). Naturalistic study design and the 
institutional practice of ECT ensured that these risk factors were uniform among the study 
participants. Unlike the studies from Europe and USA, the participants of this study were 
predominantly young men with schizophrenia. However, the estimates of self-reported, 
MMSE-defined, and autobiographical memory deficits following ECT course were 
comparable to the estimates, reported by the Western studies (Fraser et al., 2008; Rose et al., 
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2003; Sackeim et al., 2007). Only six participants were diagnosed to have depression, and the 
residual depressive symptoms were not significantly associated with the memory deficits. 
Hence, our findings indicate that service users receiving ECT may have memory deficits 
regardless of their diagnosis and severity of depression (Fernie et al., 2014).  
 Several western studies have reported that the agreement between self-reported and 
MMSE-defined memory deficits is poor (Berman et al., 2008; Brakemeier et al., 2011). Our 
findings have confirmed the poor agreement between self-reported and objective memory 
deficits following ECT in Asian settings. Besides, individual-related factors such as age and 
female gender have been associated with memory deficits (Sackeim et al., 2007; Sobin et al., 
1995). Our results have confirmed the associations with age, but not with gender. A recent 
review has reported that the relationship between the years of education, and the 
neurocognitive effects of ECT had not been investigated (McClintock et al., 2014), and our 
study has added relevant evidence. Liothyronine has been reported to reduce the memory 
deficits following ECT in people with depression, but the relationship between 
hypothyroidism and the memory deficits has not been studied (Mohagheghi et al., 2015). 
Findings of this study added evidence for the association between hypothyroidism and 
MMSE-defined memory deficits. Our results have confirmed that clinical psychiatric 
diagnoses (Ikeji et al., 1999), and anti-cholinergic medication (Calev et al., 1991) are not 
associated with the memory deficits. However, previously reported associations of the 
MMSE-defined memory deficits with pre-ECT global cognitive impairment, and the time to 
post-ECT recovery were not observed in this cohort (Sobin et al., 1995). 
  A small study (N=16) has reported that higher salivary cortisol levels were associated 
with deficits in executive function, visuospatial processing speed, and verbal memory 
following ECT (Neylan et al., 2001). Higher post-peak salivary cortisol levels have been 
associated with subjective memory complaints of older people, who had not shown any 
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deficits on objective neuropsychological testing (Peavy et al., 2013). Higher urinary cortisol 
levels have been associated with subjective memory complaints of middle aged and older 
people without any objective cognitive deficits (Wolf et al., 2005). Moreover, a 
glucocorticoid receptor antagonist, mifepristone, has been reported attenuating ECT-induced 
retrograde amnesia in rats (Nagaraja et al., 2007). This is the first study to report the 
association between serum cortisol levels and self-reported memory deficits following ECT. 
This finding indicates the possibility that the service users reporting post-ECT subjective 
memory deficits have underlying neurobiological changes that often go unnoticed. Self-
reported memory complaints following ECT cannot be readily attributed to health anxiety or 
artefacts due to direct questioning (Berman et al., 2008). They should be documented, 
discussed empathetically, and followed up periodically. Self-reported memory deficits were 
significantly associated with residual psychopathology in this cohort, and there can be a 
bidirectional relationship between serum cortisol levels and psychopathology in 
schizophrenia (Zhang et al., 2005). Service users, who have high levels of psychopathology 
at the end of their ECT course, often need complex treatment regimens after ECT. Failing to 
address their self-reported memory complaints empathetically may impact their engagement 
with the services, and their treatment adherence. 
 Neurobiology underlying various memory and non-memory cognitive deficits 
following ECT remains uncertain (McClintock et al., 2014). Age, less years of education, and 
longer duration of illness have been hypothesised to increase the risk for memory deficits 
following ECT (McClintock et al., 2014), and our findings have confirmed this. Iron 
deficiency anaemia may lead to cognitive deficits because of altered expression of brain-
derived neurotrophic factor and insulin-like growth factor (Estrada et al., 2014), and 
microcytic hypochromic anaemia was significantly associated with autobiographical memory 
deficits in this cohort. Hence, prior literature and our findings indicate that the service users, 
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who are older, lack formal education, have been chronically ill, have already received another 
course of ECT, or have anaemia or hypothyroidism, are likely to be at risk of developing 
memory deficits following ECT. Besides, the interest in the hypothesis of intra-ictal 
hypertensive surge leading to transient blood-brain barrier breach and post-ECT memory  
deficits (Andrade and Bolwig, 2014) has been rekindled by the association of 
autobiographical memory deficits with pre-ECT systolic and diastolic BP in this cohort.  
4.1. Strengths and limitations: Selection bias was minimised by recruiting all consecutive 
eligible service users, and by the null refusal rate. Availability of reliable collateral 
information from the families of all participants, and access to well-documented medical 
records reduced the possibility of recall bias. Observer bias was minimised by the two 
independent investigators, blind to each other’s findings, assessing the memory deficits and 
their correlates. However, this study has employed relatively brief cognitive assessment that 
can be incorporated into routine clinical practice, and it has not employed comprehensive 
neuropsychological assessments. It has assessed the memory deficits within a week after the 
ECT, and it did not follow their course longitudinally. Although MMSE is widely used in 
Asian settings, its scores can be affected by age, education, and cultural background 
(Tombaugh and McIntyre, 1992). The AMS has been specifically designed for the people in 
south India, but its psychometric properties needs further evaluation (Mohan et al., 2009). 
Information regarding baseline self-reported and autobiographical memory deficits were not 
recorded in medical records of any participants. Moreover, several electrophysiological 
parameters have been associated with cognitive deficits following ECT (Azuma et al., 2007; 
Sackeim et al., 2000), but routine electroencephalographic monitoring was not feasible in our 
setting.  
4.2. Future directives: The American Psychiatric Association task force report on ECT 
recommended weekly objective cognitive assessments, and documenting service users’ 
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reports in 2001 (APA, 2001). Many European professional organisations have suggested 
periodic cognitive assessments before, during, and after a course of ECT (Porter et al., 2008). 
However, these recommendations are not routinely implemented in most of the Asian clinical 
settings (Leiknes et al., 2012; Rajkumar et al., 2006, 2007). High numbers of service users 
receiving ECT, resource limitations, cross-cultural issues in cognitive assessment, unequal 
physician-patient relationships, and difficulties in generalising Western research findings to 
Asian settings contribute to this shortcoming. Findings of this research highlight the need for 
periodic cognitive assessments evaluating multiple cognitive domains of all service users 
before, during, and after a course of ECT, and the need to formulate specific guidelines for 
Asian settings. Although short culturally-modified cognitive assessment batteries often have 
suboptimal sensitivity, they may help overcoming the hurdles in improving the quality of care 
in many clinical settings practising ECT. A short assessment battery for ECT related 
cognitive deficits has been developed, and used in a small sample of service users (N=30) in 
south India (Viswanath et al., 2013). This research has confirmed the feasibility of employing 
another short cognitive assessment battery in a relatively larger south Indian cohort that 
received ECT. Identified correlates of memory deficits following ECT indicate the need for 
more frequent follow-up of specific subgroups of service users, and may help prioritisation 
and resource allocation. There is a need for further research developing and validating 
culturally-appropriate cognitive assessment instruments for Asian settings. Longitudinal 
Asian studies investigating the course of ECT related cognitive deficits, and further 
investigations of underlying neurobiology are warranted. 
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Figure legends: 
Figure-1: Overlap between self-reported, MMSE-defined, and autobiographical memory 
deficits following ECT (N=76) 
Self-reported: Participants self-reportedly reporting moderate to extremely severe memory 
deficits in a six point Likert scale; AMS: Autobiographical memory scale total score less than 
40; MMSE: MMSE-defined memory deficits, defined by participants failing seven or more 
items of Mini Mental Status Examination. 
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Table-1: Sociodemographic and clinical characteristics of the participants (N=76)  
a Other diagnoses include schizoaffective disorder (ICD-10 F25; n=4), acute psychoses (ICD-
10 F23; n=3), and persistent delusional disorder (ICD-10 F22; n=1). 
Characteristics N (%) / Mean (SD) 
Men 43 (56.6) 
Age (years) 29.1 (8.7) 
Number of years of formal education  11.6 (4.1) 
 
 
Clinical Diagnosis 
Schizophrenia 47 (61.8) 
Mania 15 (19.7) 
Depression 6 (7.9) 
Others a 8 (10.5) 
High risk of suicide before Electroconvulsive therapy (ECT) 20 (26.3) 
Pre-ECT Mini Mental Status Examination total score (n=72) 28.7 (1.8) 
Post-ECT Mini Mental Status Examination total score 23.6 (4.6) 
Post-ECT Brief Psychiatric Rating Scale total score  28.3 (9.4) 
Number of ECT in this course 9.5 (1.8) 
Has received one more course of ECT in the past 12 (17.6) 
Mean ECT energy level (millicoulombs) 124.0 (46.3) 
Mean duration of motor seizures (seconds) 37.9 (8.0) 
Mean dose of Sodium thiopental (mg)   172.2 (32.7) 
Mean dose of Suxamethonium chloride (mg) 30.2 (8.4) 
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Table-2: Agreement between self-reported, MMSE-defined, and autobiographical memory 
deficits following ECT 
Memory deficit Self-reported Autobiographical Post-ECT 
MMSE  
failed items 
≥ 7 
Pre-ECT - 
post-ECT 
MMSE total 
scores ≥ 7a 
Self-reported 1    
Autobiographical 0.02 (0.11; 
0.89) 
1   
Post-ECT MMSE  
failed items ≥ 7 
0.07 (0.11; 
0.55) 
0.23 (0.11; 0.04) 1  
Pre-ECT - post-
ECT MMSE total 
scores ≥ 7a 
0.12 (0.12; 
0.30) 
0.32 (0.11; 0.006) 0.91 (0.05; 
<0.001) 
1 
 
Each cell presents the kappa statistic with its standard error and p value in parentheses; Self-
reported: Participants reported moderate to extremely severe memory deficits in a six point 
Likert scale, following Electro Convulsive Therapy (ECT) (N=76); Autobiographical: 
Autobiographical memory scale total score less than 40 (median value) following ECT 
(N=76); MMSE: Mini Mental Status Examination; a Pre-ECT MMSE total scores were 
available only for 72 participants; Statistically significant (p<0.05) findings have been 
presented in bold. 
 
Table-3: Participant and illness related factors associated with memory deficits following 
ECT (N=76) 
AC
CE
PT
ED
 M
AN
US
CR
IPT
26 
 
 
Explanatory variable 
Self-reported a MMSE-defined 
b 
Autobiographical c 
ARR (95% 
CI) 
p ARR 
(95% CI) 
p ARR (95% 
CI) 
p 
Age (in years)d 1.03 (0.99-
1.06) 
0.11 1.03 
(1.00-
1.05) 
0.03 1.02 (1.00-
1.04) 
0.02 
Male gender 0.87(0.42-
1.81) 
0.71 1.42 
(0.63-
3.18) 
0.39 1.11 (0.63-
1.97) 
0.72 
Rural residence 0.99 (0.48-
2.03) 
0.98 1.19 
(0.64-
2.20) 
0.58 0.54 (0.29-
0.99) 
0.04 
Number of years of 
education 
1.06 (0.98-
1.16) 
0.14 0.92 
(0.84-
0.99) 
0.04 0.97 (0.91-
1.05) 
0.48 
Presence of suicidal risk  0.85 (0.37-
1.99) 
0.72 1.09 
(0.54-
2.18) 
0.81 1.45 (0.81-
2.60) 
0.22 
History of catatonia  1.10 (0.38-
3.16) 
0.86 1.40 
(0.75-
2.61) 
0.29 0.63 (0.18-
2.20) 
0.47 
Duration of illness more 
than two years 
1.43 (0.58-
3.51) 
0.44 2.27 
(1.02-
5.05) 
0.04 1.50 (0.75-
3.02) 
0.25 
Presence of anaemia e 1.65 (0.68-
3.98) 
0.27 0.92 
(0.44-
1.90) 
0.81 2.31 (1.18-
4.54) 
0.02 
Presence of dyslipidaemia 0.70 (0.24-
2.03) 
0.51 0.65 
(0.31-
0.25 1.23 (0.63-
2.41) 
0.55 
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1.35) 
Presence of 
hypothyroidism 
1.50 (0.44-
5.07) 
0.51 1.88 
(1.11-
3.15) 
0.02 1.48 (0.69-
3.19) 
0.32 
Serum cortisol level 
(µg/dL) following ECT 
1.14 (1.05-
1.24) 
0.001 1.04 
(0.99-
1.08) 
0.14 1.00 (0.94-
1.06) 
0.95 
Residual psychopathology 
f 
1.02 (1.00-
1.04) 
0.02 0.99 
(0.97-
1.01) 
0.50 1.04 (0.95-
1.15) 
0.37 
Residual depressive 
symptoms g 
1.38 (0.82-
2.33) 
0.22 0.82 
(0.66-
1.03) 
0.09 0.86 (0.60-
1.23) 
0.40 
Each cell presents a multivariate generalised linear model with binomial distribution and log-
link function. Each model included hypothesised explanatory variable, defined memory 
deficit (dependent variable), and age (in years) as well as the number of ECTs as covariates; 
ARR: Adjusted risk ratio;  a participant reported moderate to extremely severe cognitive 
deficits in a six point Likert scale, following ECT; b Participant failed seven or more items of 
Mini Mental Status Examination (MMSE), following ECT; c Autobiographical memory scale 
total score less than 40 (median value); d This row included age (in years) as explanatory 
variable, defined memory deficit as dependent variable, and the number of ECTs as 
covariate; e Microcytic hypochromic anaemia was documented in the medical records by the 
treating psychiatrists; f Total score of Brief Psychiatric Rating Scale (BPRS), 18 items 
version; g Score on BPRS “Depressive mood” item (Item 9);  Statistically significant (p<0.05) 
findings have been presented in bold. 
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Table-4: Treatment related factors associated with memory deficits following ECT (N=76) 
 
Explanatory variable 
Self-reported a MMSE-defined b Autobiographical c 
ARR 
(95% CI) 
p ARR 
(95% CI) 
p ARR (95% 
CI) 
p 
Past history of another 
course of ECT  
0.29 
(0.03-
1.56) 
0.13 2.07 
(1.19-
3.58) 
0.01 1.92 (1.01-
3.64) 
0.04 
Number of ECTs in this 
course 
0.97 
(0.80-
1.18) 
0.75 1.06 
(0.91-
1.22) 
0.46 1.18 (0.98-
1.41) 
0.07 
Anticholinergic co-
medication during ECTd 
0.53 
(0.24-
1.17) 
0.12 0.88 
(0.51-
1.52) 
0.66 1.56 (0.82-
2.96) 
0.18 
Benzodiazepine co-
medication during ECT 
1.31 
(0.60-
2.88) 
0.50 1.18 
(0.65-
2.12) 
0.59 1.49 (0.75-
2.98) 
0.26 
Mean pre-ECT systolic BP 
(mm Hg) 
0.99 
(0.96-
1.01) 
0.31 1.02 
(1.00-
1.04) 
0.07 1.03 (1.01-
1.06) 
0.009 
Mean pre-ECT diastolic BP 
(mm Hg) 
0.99 
(0.94-
1.04) 
0.70 1.02 
(1.00-
1.05) 
0.09 1.05 (1.02-
1.09) 
0.001 
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Mean dose of Sodium 
thiopental (mg) 
1.00 
(0.99-
1.01) 
0.65 1.00 
(0.99-
1.01) 
0.84 1.00 (0.98-
1.01) 
0.82 
Mean dose of 
Suxamethonium chloride 
(mg) 
0.97 
(0.93-
1.01) 
0.20 0.97 
(0.93-
1.02) 
0.26 1.03 (0.94-
1.13) 
0.56 
Mean ECT energy level 
(millicoulombs) 
1.00 
(0.99-
1.01) 
0.76 1.00 
(1.00-
1.01) 
0.20 1.00 (0.99-
1.01) 
0.78 
Mean duration of motor 
seizures (seconds) 
1.01 
(0.96-
1.05) 
0.80 1.00 
(0.95-
1.05) 
0.94 0.98 (0.94-
1.01) 
0.14 
Mean post-ECT oxygen 
saturation (%) 
0.98 
(0.86-
1.11) 
0.77 0.73 
(0.47-
1.15) 
0.18 1.10 (0.15-
8.16) 
0.92 
Mean time to post-ECT 
recovery (minutes) 
1.02 
(0.97-
1.08) 
0.35 1.00 
(0.95-
1.05) 
0.93 0.98 (0.93-
1.04) 
0.58 
 
Each cell presents a multivariate generalised linear model with binomial distribution and log-
link function. Each model included hypothesised explanatory variable, defined memory 
deficit (dependent variable), and age (in years) as well as number of ECTs as covariates; 
ARR: Adjusted risk ratio;  a participant reported moderate to extremely severe cognitive 
deficits in a six point Likert scale, following ECT; b Participant failed seven or more items of 
Mini Mental Status Examination (MMSE), following ECT; c Autobiographical memory scale 
total score less than 40 (median value); Statistically significant (p<0.05) findings have been 
presented in bold; d Presence of regular prescription of anticholinergic medication during the 
course of ECT. 
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